Research set to improve processes for NHS drug approvals

Research set to improve processes for NHS drug approvals. Researchers from the University of Sheffield and the University of Liverpool have identified ways in which the process of approving drugs for use on the NHS can be improved. The study, entitled The NICE Single Technology Appraisal Process: Lessons from the first four years , was co-authored by Eva Kaltenthaler and Diana Papaioannou from the University of Sheffield and Angela Boland and Rumona Dickson of the University of Liverpool. The National Institute for Health and Clinical Excellence, (NICE) set up the Single Technology Appraisal (STA) process in 2005 as a method of examining whether new drugs are both clinically and cost effective. During the STA process, manufacturers prepare a submission of evidence to support their drug. The University of Sheffield's School of Health and Related Research (ScHARR) is one of seven centres in the UK that provides independent academic analysis of these submissions to identify strengths and weaknesses. These academic groups are known as Evidence Review Groups (ERGs).
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login

Your Benefits

  • Access to all content
  • Receive newsmails for news and jobs
  • Post ads

myScience